AgiBot (Zhiyuan)

Humanoid Robots·Private

Tech Score Building OPINION

Goal milestone Mass-produced general-purpose humanoids

Shanghai humanoid maker; Omdia's #1 in global 2025 shipments (5,168 units, ~39% share).

Founded2023 HQShanghai, China Websitewww.agibot.com ↗

Technology ↔ market gap

Verified technical progress over time. Market valuation overlays once delayed data connects.

Technical progress Market valuation

—

No verified stage yet — it appears once milestones are stage-tagged.

Verified stage

Not yet staged

Market-impliedAwaiting market data

GapOPINIONAwaiting market data

Catalysts

Stock-moving events from the newsroom feed — facts, not advice. No rating, no price target.

2026-07-28

Regulatory

The US bans new Chinese humanoid robots — a national-security wall around the robot buildout

source · CNBC ↗ read ↗

2026-07-02

Commercialization

AgiBot debuts the A3 humanoid in Europe and launches a UK robots-as-a-service model

source · AgiBot (PR Newswire) ↗ read ↗

2026-06-29

Commercialization

AgiBot's six-day factory livestream ends: 64,828 tasks at a 99.99% success rate

source · AgiBot ↗ read ↗

2026-06-28

Commercialization

AgiBot's 15,000th robot rolls off the line as G2 deploys at a tablet factory

source · AgiBot via PR Newswire ↗ read ↗

Technical milestones

Verified progress on the Frontier Milestones tracker ↗

From the verified Frontier Milestones dataset.

No actor-attributed milestones tracked yet.

Market data

Cumulative funding$84M

Quantitative factors

Computed once market data connects (price, market cap, runway).

Commentary

No analyst commentary published yet.

Commentary reflects one analyst’s view and is not a recommendation. It is presented alongside factual data and is explicitly labelled opinion.

Discussion0

Member discussion. Not investment advice, solicitation, or a recommendation.

Loading…

LICENSE-GATED Ratings & price targets are not shown. FM Invest does not display buy / hold / sell ratings or price targets until investment-advisory licensing is in place. The schema exists and is gated to zero exposure until then.

For information only. Not investment advice and not a solicitation. Market data is delayed and provided “as is”; technical data is read from the Frontier Milestones verified dataset.